Physician profile
Shernett Griffiths
NPI 1245495423
$9,001.11
in general payments reported to CMS, 2019-2025
50 companies · $1,590 in 2025
The $1,590 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,851 · 2020: $307 · 2021: $983 · 2022: $983 · 2023: $1,844 · 2024: $1,443 · 2025: $1,590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,587 · Education: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,586.70 |
| Education | $289.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,405.04 | 2019-2025 | Enbrel, Tavneos, Krystexxa |
| Abbvie INC. | $1,203.42 | 2019-2025 | |
| Janssen Biotech, INC. | $1,047.94 | 2019-2025 | Tremfya, Simponi Aria, Simponi |
| Horizon Therapeutics Plc | $759.94 | 2019-2023 | Krystexxa |
| Glaxosmithkline, LLC. | $577.53 | 2019-2025 | Trelegy Ellipta, Arexvy, Benlysta |
| Novartis Pharmaceuticals Corporation | $540.81 | 2019-2025 | |
| Genzyme Corporation | $500.34 | 2019-2025 | |
| Lilly USA, LLC | $439.83 | 2021-2024 | Taltz |
| Pfizer INC. | $357.42 | 2019-2024 | |
| Ucb, INC. | $341.16 | 2022-2025 | Cimzia, Bimzelx |
| Genentech USA, INC. | $227.14 | 2019-2020 | |
| Novo Nordisk INC | $148.13 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.70 | 2022-2024 | Cyltezo, Ofev |
| E.R. Squibb & Sons, L.L.C. | $104.20 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $81.18 | 2019 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shernett Griffiths listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.